相关实验视频
Updated: May 29, 2025

06:05
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
3.7K
基因疗法预防肝脏线粒体功能障碍在小鼠deoxyguanosine激酶缺乏症
Nandaki Keshavan1,2,3, Miriam Greenwood1, Helen Prunty4
1UCL GOS Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK.
Molecular therapy. Methods & clinical development
|February 3, 2025
概括
使用AAV9的基因疗法成功治疗了DGUOK缺乏症小鼠模型,防止新生儿肝衰竭. 这种方法为线粒体DNA枯竭综合征提供了潜在的疾病修饰疗法.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 主要线粒体疾病可以导致新生儿肝衰竭.
- DGUOK基因变异导致肝脑线粒体DNA枯竭综合征,导致肝功能衰竭和死亡.
- 目前没有有效的疾病修饰疗法存在这种情况.
研究的目的:
- 开发和评估一种针对DGUOK缺乏症的腺相关病毒9 (AAV9) 基因疗法.
- 为了治疗一个复制人类DGUOK缺乏相关的肝病的小鼠模型.
主要方法:
- 携带人类DGUOK基因 (AAV9-hDGUOK) 的AAV9静脉输送给新生Dguok淘汰小鼠.
- 剂量依赖的管理,以评估治疗疗效.
- 监测肝功能障碍,线粒体DNA水平,氧化酸化复合体活性,肝酶和生存率.
主要成果:
- 服用AAV9-hDGUOK可以以剂量依赖的方式预防肝功能障碍.
- 观察到持久和长期的肝转导和RNA表达.
- 线粒体DNA枯竭,氧化酸化缺陷,高转氨酶和死亡率都得到了剂量依赖的改善.
结论:
- 基于AAV9的基因疗法是治疗DGUOK缺乏症的一个有希望的方法.
- 这种疗法有效地预防和改善关键疾病表型在一个相关的小鼠模型.
- 这些发现支持基因疗法作为新生儿肝功能衰竭由于DGUOK缺乏症的疾病修饰治疗的潜力.
相关概念视频
In-vitro Mutagenesis
13.7K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.7K
Animal Mitochondrial Genetics
7.4K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.4K
Gene Therapy
25.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.1K

